N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014951 |
| CAS No | NA |
| Mol.F. | C19H19N7O4 |
| Mol.Wt. | 409.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014952 |
| CAS No | NA |
| Mol.F. | C19H20N6O3 |
| Mol.Wt. | 380.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014953 |
| CAS No | 2768787-11-5 |
| Mol.F. | C25H27N7O2 |
| Mol.Wt. | 475.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014954 |
| CAS No | NA |
| Mol.F. | C25H27N7O2 |
| Mol.Wt. | 457.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014955 |
| CAS No | NA |
| Mol.F. | C11H17N3O2 |
| Mol.Wt. | 223.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014956 |
| CAS No | 2826147-23-1 |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014957 |
| CAS No | NA |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014958 |
| CAS No | NA |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014959 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014960 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014961 |
| CAS No | 77817-40-4 |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014962 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014963 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014964 |
| CAS No | NA |
| Mol.F. | C5H11N3O |
| Mol.Wt. | 129.16 |
| INV STATUS | In Stock |
| CAT No | SRC-N014965 |
| CAS No | NA |
| Mol.F. | C20H22N2O2 |
| Mol.Wt. | 322.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014966 |
| CAS No | NA |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.2 |
| INV STATUS | UNDER SYNTHESIS |